Bill A
Department of Physiology and Medical Biophysics, Biomedical Center, University of Uppsala, Sweden.
Prog Clin Biol Res. 1989;312:417-27.
Uveoscleral outflow can account for 35% to 60% of total outflow in monkeys, although only for a much lesser fraction in cats and rabbits. Accurate assessment of the percentage of outflow via this route in humans is more difficult. In human eyes, this value was found to be in the 5% to 25% range by isotope studies, although calculations based on non-invasive methods have suggested a value of about 35% in normal eyes. In monkey eyes, the rate of uveoscleral outflow is not much affected by IOP but it can be increased by surgical and pharmacological means. Epinephrine, for example, has been found to increase uveoscleral outflow, possibly mediated by endogenously synthesized PGs. In monkeys, observed increases in uveoscleral outflow following administration of very small PG doses equal or exceed the increase that can be achieved with much higher doses of epinephrine. These observations support the concept that PGs may represent an important new approach to the medical management of glaucoma.
在猴子中,葡萄膜巩膜流出量可占总流出量的35%至60%,而在猫和兔子中所占比例则小得多。准确评估人类通过该途径的流出量百分比更为困难。通过同位素研究发现,在人眼中,该值在5%至25%的范围内,尽管基于非侵入性方法的计算表明正常眼睛中的值约为35%。在猴眼中,葡萄膜巩膜流出率受眼压的影响不大,但可以通过手术和药理学方法增加。例如,已发现肾上腺素可增加葡萄膜巩膜流出量,可能是由内源性合成的前列腺素介导的。在猴子中,给予非常小剂量的前列腺素后观察到的葡萄膜巩膜流出量增加等于或超过用高得多的肾上腺素剂量所能达到的增加量。这些观察结果支持这样一种概念,即前列腺素可能代表青光眼药物治疗的一种重要新方法。